MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock in...
$230,000K
Proceeds from exercise of
stock options
$956K
Net cash provided by
(used in) financing...
$214,731K
Canceled cashflow
$16,225K
Net increase
(decrease) in cash and cash...
$148,412K
Canceled cashflow
$66,319K
Payment of financing
cost in connection...
$14,247K
Payment of contingent
value right liability
$1,978K
Stock-based compensation
$3,376K
Non-cash interest
expense - royalty...
$2,039K
Accounts payable
$851K
Change in fair value of
derivative liabilities -...
$116K
Non-cash lease operating
expense
$44K
Net cash used in
investing activities
-$55,440K
Net cash used in
operating activities
-$10,864K
Effect of exchange rate
change on cash and cash...
-$15K
Canceled cashflow
$6,426K
Purchase of marketable
securities
$55,440K
Net loss
-$15,767K
Accrued expenses and
other current...
-$900K
Prepaid expenses and
other current assets
$357K
Change in fair value of
derivative liabilities -...
-$202K
Payments on operating
lease liabilities
-$49K
Accretion on marketable
securities
$15K
Back
Back
Cash Flow
PALVELLA THERAPEUTICS, INC. (PVLA)
PALVELLA THERAPEUTICS, INC. (PVLA)
source: myfinsight.com